Literature DB >> 27626648

[Prevalence of diabetes mellitus and associated factors in indigenous women in Dourados, Mato Grosso do Sul State, Brazil].

Glênio Alves de Freitas1, Maria Cristina Corrêa de Souza1, Rosangela da Costa Lima1.   

Abstract

This study's objective was to estimate the prevalence of abnormal casual capillary blood glucose, suggestive of diabetes mellitus, and the associations with socioeconomic, demographic, anthropometric, and clinical factors in indigenous women in Dourados, Mato Grosso do Sul State, Brazil. This was a cross-sectional study with a probabilistic sample of women 18 to 59 years of age in the Bororó and Jaguapiru villages. A standardized questionnaire was used to collect data, and statistical analysis used the Kruskal-Wallis, Mann-Whitney, and generalized linear model tests. Of the 385 women, 7% showed abnormal casual capillary blood glucose, suggestive of diabetes mellitus. In the final generalized linear model, the following remained associated with the outcome: age (p < 0.001), systolic blood pressure (p = 0.002), and ethnicity (p = 0.022). The study shows the need for behavior changes, using educational interventions as a strategy for the prevention and control of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27626648     DOI: 10.1590/0102-311X00023915

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  COVID-19 pandemic evolution in the Brazilian Indigenous population.

Authors:  Matheus Ferreira Mendes; Letícia Rogini Pereira; Tainá Momesso Lima; Vitória Franchini Melani; Camila Vantini Capasso Palamim; Matheus Negri Boschiero; Fernando Augusto Lima Marson
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-29

2.  COVID-19 and Brazilian Indigenous Populations.

Authors:  Graziela Almeida Cupertino; Marli do Carmo Cupertino; Andréia Patrícia Gomes; Luciene Muniz Braga; Rodrigo Siqueira-Batista
Journal:  Am J Trop Med Hyg       Date:  2020-06-09       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.